Sarcoma Service at Memorial Sloan Kettering
@MSKSarcoma
Followers
701
Following
255
Media
7
Statuses
114
For more than 135 years, we have been united by a singular purpose: to find cures for sarcomas. 1-844-923-0361 (new pts) | [email protected] (doctors)
New York, NY
Joined July 2020
RT @SARCtrials: The July episode of #SARCTalk features Dr. Mark Dickson, MD from @MSKCancerCenter sharing valuable insight on #liposarcoma.….
open.spotify.com
SARC Talk · Episode
0
2
0
Featured today by @MSKLibrary: A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma
aacrjournals.org
AbstractPurpose:. Epacadostat, an indole 2,3 dioxygenase 1 (IDO1) inhibitor, proposed to shift the tumor microenvironment toward an immune-stimulated state, showed early promise in melanoma but has...
0
1
2
RT @CancerResearch: "This grant is meaningful to me because it allows me to continue my research which is focused on novel immunotherapies….
0
5
0
RT @MSKCancerCenter: On 4/26, we're launching a global educational series on molecular oncology, co-directed by MSK's Dr. Mrinal Gounder an….
0
5
0
RT @sandrapdangelo: Dr. Kelly shows that pembrolizumab + epacadostat is ineffective in #sarcoma but correlative studies noted lack of IDO i….
0
9
0
We are thrilled to welcome Dr. Bob Maki back to the MSK family. Dr. Maki brings long-standing expertise in #sarcoma through innovative research and trials. A dedicated colleague, mentor, friend and a compassionate clinician. Clinics in Manhattan and Nassau campus. Welcome Bob!
4
18
119
RT @sandrapdangelo: As a recipient of numerous ASCO Conquer Cancer grants, I can attest to the power and value of these opportunities. http….
0
4
0
Nirogacestat, a New Desmoid Tumor Treatment, Improves Outcomes for People With Sarcoma @AimeeCragoMD Dr. Sam Singer, MSK, Dr. Joe Erinjeri, Dr. Robert Lefkowitz @DTRFoundation @AmericanCancer @SpringWorksTx @RareDiseases @debschrag.
mskcc.org
The FDA has approved nirogacestat (OgsiveoTM), a targeted therapy for desmoid tumors. A recent phase 3 clinical trial found that the drug significantly shrank desmoid tumors in 41% of patients....
0
1
13
Congratulations to all desmoid pts/families, pt advocacy @DTRFoundation, Mrinal Gounder @MSKCancerCenter desmoid team, co-investigators globally, @SpringWorksTx. A great model for drug development in @RareDiseases - pt advocacy working together w academia, industry & regulators.
2
1
8
RT @HodaAndJenna: Mrs. @MichelleObama has received nearly 2,000 letters every month — which are part of the inspiration behind her new book….
0
159
0
RT @sandrapdangelo: MSK fellow extraordinaire, Dr. Lauren Banks provides insightful perspective into the status of immunotherapy for sarcom….
0
10
0
RT @CureSarcoma: Rare, often misdiagnosed, accounts for 1% of all adult cancers and 15 to 20% of childhood cancers. In 2022, an estimated 1….
0
43
0
RT @SarcomaAlliance: It's officially #SarcomaAwarenessMonth. Will you retweet to raise sarcoma awareness?
0
58
0
RT @MSKCancerCenter: Excited to announce @DrVickersUAB of @uabnews has been selected to serve as MSK President and CEO beginning this Septe….
mskcc.org
Memorial Sloan Kettering Cancer Center (MSK) today announced that Selwyn M. Vickers, MD, FACS, an internationally recognized pancreatic cancer surgeon and researcher, a pioneer in cancer health...
0
96
0
RT @sandrapdangelo: Nivolumab with bempegaldesleukin in sarcoma now published in @NatureComms. A collaborative effort with my colleagues @M….
nature.com
Nature Communications - The activity of PD-1 blockade in patients with sarcoma has been modest so far. Here, the authors report the results of a pilot clinical trial to assess the efficacy and...
0
31
0
RT @BenNacev: Our latest work is out in @NatureComms. With @fsanchezvega, @WTapMD, Samuel Singer, and colleagues at @MSKSarcoma.@MSKCancerC….
0
61
0
RT @AimeeCragoMD: We're looking for a new postdoc to help with our NIH project on #desmoid tumors. Email or DM if you know someone who mig….
0
10
0